FDA Inspection
Merck & Co IncMerck & Co Inc – FDA Inspection, Sep 20, 2016
Record Details
This FDA Inspection record concerns Merck & Co Inc, with an inspection on September 20, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Merck & Co Inc
- Inspection Date
- September 20, 2016
- Product Type
- Drugs
View Company Profile
ID · d94aa913-b79d-4b41-93df-116c588a5faf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 988466
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Merck & Co Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 1, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 1, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 12, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 8, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Merck & Co Inc
- FDA Inspection 1219020 - 2023-09-01
- FDA Inspection 1071196 - 2018-11-01
- FDA Inspection 970042 - 2016-04-12
- FDA Inspection 849685 - 2013-10-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.